Shares of WORK Medical Technology Group slipped to $2.10 in pre-market trading Monday, erasing a chunk of last week's sharp rebound that had lifted the micro-cap stock from $1.96 to $2.30 in just two sessions — a roughly 17% sprint fueled by buzz around its new artificial-intelligence biotech partnership and blockchain-based healthcare data initiative. WOK Drops 8.7% in Pre-Market as Traders Cash In on AI-Blockchain Rally — Can a $5 Million Company Deliver on Its Moonshot Bets?
Shares of WORK Medical Technology Group stumbled to $2.10 before the opening bell Monday, giving back a sizable portion of last week's 17% surge from $1.96 to $2.30. No new company announcement, regulatory filing, or earnings catalyst appeared overnight. The move looks squarely like profit-taking — traders who rode the AI-biotech and blockchain hype locking in gains. For a stock with this history of violent swings, the real question is whether anything underneath the press releases can sustain the price.
A Tiny Company Making Very Big Promises
With a market cap of roughly $5 million , trailing twelve-month revenue of just $9.8 million, and a net loss of $1.1 million , WORK Medical is a micro-cap Chinese medical-device maker whose core business is disposable hospital supplies — endotracheal tubes, breathing circuits, and nebulizer kits . It is now layering on AI partnerships, blockchain tokenization schemes, and a Web3.0 alliance. The gap between the ambition and the balance sheet is enormous.
The Rally Was Built on Press Releases, Not Revenue The recent run was powered by two announcements: a partnership with Novabioplus to mine biological data using AI and advance a "biotoken" model that would turn biological information into tradable digital assets , and a strategic tie-up with the Hong Kong Web3.0 Standardization Association to develop blockchain-based asset tokenization and real-world-asset technology . Neither deal disclosed concrete revenue terms or timelines. For shareholders, this means the upside is still entirely theoretical.
This Stock Has Crashed Before on the Same Pattern
In May 2026, WOK shares dropped 46% in a single pre-market session after a similar speculative blowoff , and that slide also came with no fresh positive fundamental news to back the earlier spike . Today's 8.7% dip is far milder, but it follows the same script: hype-driven rally, exhaustion, selloff.
The Financial Foundation Remains Shaky
WORK Medical carries a −10.9% net profit margin and diluted earnings of −$0.04 per share . Analysts note deteriorated profitability and contracting revenue alongside bearish technical momentum . Until the AI and blockchain ventures generate actual income, every rally rests on sentiment alone — and sentiment, as this morning shows, can reverse overnight.